Biopol Chemicals (NSE:BIOPOL) Total Equity: ₹499.2 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:BIOPOL Biopol Chemicals Ltd NSE:BIOPOL
20 GF Score
Price ₹97.80
! 4 Warning Signs
View Full Analysis

What is Biopol Chemicals Total Equity?

Biopol Chemicals NSE:BIOPOL +0.31% 20 Total Equity is ₹499.2 Mil as of Mar. 2026. GuruFocus rates NSE:BIOPOL with a GF Score™ of 20/100. The stock has 4 warning signs investors should review.

Biopol Chemicals's total equity for the quarter that ended in Mar. 2026 was ₹499.2 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Biopol Chemicals Total Equity Historical Data

* Premium members only.

The historical data trend for Biopol Chemicals's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biopol Chemicals Total Equity Chart

Biopol Chemicals Annual Data
Trend Mar24 Mar25 Mar26
Total Equity
92.01 135.31 499.21

Biopol Chemicals Semi-Annual Data
Mar24 Mar25 Mar26
Total Equity 92.01 135.31 499.21
NSE:BIOPOL
20GF Score
Biopol Chemicals Ltd NSE:BIOPOL
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biopol Chemicals Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Biopol Chemicals's Total Equity for the fiscal year that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=697.753-198.544
=499.2

Biopol Chemicals's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=697.753-198.544
=499.2

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ₹499.2 Mil mean?
Biopol Chemicals (NSE:BIOPOL) has a Total Equity of ₹499.2 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Biopol Chemicals and its competitors.
Is Biopol Chemicals' Total Equity too high?
Biopol Chemicals' current Total Equity is ₹499.2 Mil. Overall, Biopol Chemicals has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Biopol Chemicals' Total Equity compare to LIN and SHW?
Biopol Chemicals' Total Equity of ₹499.2 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Chemicals company?
A good Total Equity depends on the Chemicals industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Biopol Chemicals and its competitors. Biopol Chemicals's current Total Equity is ₹499.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biopol Chemicals stock overvalued right now?
Biopol Chemicals (NSE:BIOPOL) has a current Total Equity of ₹499.2 Mil. The current Total Equity is ₹499.2 Mil. Biopol Chemicals' overall GF Score™ is 20/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Biopol Chemicals (NSE:BIOPOL), the current Total Equity is ₹499.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biopol Chemicals Business Description

Address Street No 372 Action Area 1, Unit No 2ES3B1, 2nd Floor Mani Casadona, IIF Newtown Alia University, North 24 Parganas, Chakpachuria, New town, WB, IND, 700160
Biopol Chemicals Ltd is engaged in the business of trading, manufacturing and distribution of specialty chemicals under the categories of silicones, emulsifiers, biochemicals and polyelectrolytes. Its product portfolio consists of silicone-based products, emulsifier-based products, biochemical products and polyelectrolyte products. It serves various industry segments, including softeners, emulsions and hardeners for textiles; silicone fluids and cleaning chemicals for home care; silicone adjuvants and surfactants in agriculture; and release agents in industrial chemicals. The majority of the company's revenue is derived from the sale of its products to customers in the textile sector.
20GF Score

Get the complete analysis for NSE:BIOPOL

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹97.80
Price